The 3 analysts offering 12-month price forecasts for Alpine Immune Sciences Inc have a median target of 21.00, with a high estimate of 22.00 and a low estimate of 19.00. The median estimate represents a +97.74% increase from the last price of 10.62.
The current consensus among 4 polled investment analysts is to Buy stock in Alpine Immune Sciences Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.02
Reporting Date Nov 18
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.